Citation: K. Hemminki et Ch. Dong, Subsequent cancers after in situ and invasive squamous cell carcinoma of the skin, ARCH DERMAT, 136(5), 2000, pp. 647-651
Citation: M. Koskinen et K. Hemminki, Separate deamination mechanisms for isomeric styrene oxide induced N-1-adenine adducts, ORG LETT, 1(8), 1999, pp. 1233-1235
Authors:
Somorovska, M
Jahnova, E
Tulinska, J
Zamecnikova, M
Sarmanova, J
Terenova, A
Vodickova, L
Liskova, A
Vallova, B
Soucek, P
Hemminki, K
Norppa, H
Hirvonen, A
Tates, AD
Fuortes, L
Dusinska, M
Vodicka, P
Citation: M. Somorovska et al., Biomonitoring of occupational exposure to styrene in a plastics laminationplant, MUT RES-F M, 428(1-2), 1999, pp. 255-269
Citation: Cy. Zhao et al., Endogenous and background DNA adducts by methylating and 2-hydroxyethylating agents, MUT RES-F M, 424(1-2), 1999, pp. 117-125
Authors:
Vodicka, P
Tvrdik, T
Osterman-Golkar, S
Vodickova, L
Peterkova, K
Soucek, P
Sarmanova, J
Farmer, PB
Granath, F
Lambert, B
Hemminki, K
Citation: P. Vodicka et al., An evaluation of styrene genotoxicity using several biomarkers in a 3-yearfollow-up study of hand-lamination workers, MUT RES-GTE, 445(2), 1999, pp. 205-224
Authors:
Hemminki, K
Palmgren, J
Korhonen, P
Partanen, R
Brandt-Rauf, P
Rautalahti, M
Albanes, D
Virtamo, J
Citation: K. Hemminki et al., Serum epidermal growth factor receptor and p53 as predictors of lung cancer risk in the ATBC study, BIOMARKERS, 4(1), 1999, pp. 72-84
Citation: R. Kumar et al., Loss of heterozygosity at chromosome 9p21 (INK4-p14(ARF) locus): homozygous deletions and mutations in the p16 and p14(ARF) genes in sporadic primarymelanomas, MELANOMA RE, 9(2), 1999, pp. 138-147
Citation: K. Hemminki et P. Vaittinen, Familial cancers in a nationwide family cancer database: Age distribution and prevalence, EUR J CANC, 35(7), 1999, pp. 1109-1117
Citation: K. Hemminki et P. Vaittinen, Familial risks in second primary breast cancer based on a family cancer database, EUR J CANC, 35(3), 1999, pp. 455-458
Authors:
Kim, DY
Cho, MH
Yang, HK
Hemminki, K
Kim, JP
Jang, JJ
Kumar, R
Citation: Dy. Kim et al., Detection of methylation damage in DNA of gastric cancer tissues using P-32-postlabelling assay, JPN J CANC, 90(10), 1999, pp. 1104-1108
Authors:
Eide, I
Zhao, CY
Kumar, R
Hemminki, K
Wu, KY
Swenberg, JA
Citation: I. Eide et al., Comparison of P-32-postlabeling and high-resolution GC/MS in quantifying N7-(2-hydroxyethyl)guanine adducts, CHEM RES T, 12(10), 1999, pp. 979-984
Authors:
Yang, K
Lindblad, P
Egevad, L
Hemminki, K
Citation: K. Yang et al., Novel somatic mutations in the VHL gene in Swedish archived sporadic renalcell carcinomas, CANCER LETT, 141(1-2), 1999, pp. 1-8
Authors:
El-Rifai, W
Tarmo, L
Hemmer, S
Forsti, A
Pedersen, N
Lichtenstein, P
Ahlbom, A
Soderberg, M
Knuutila, S
Hemminki, K
Citation: W. El-rifai et al., DNA copy number losses at 1p32-pter in monozygotic twins concordant for breast cancer, CANC GENET, 112(2), 1999, pp. 169-172
Authors:
Hou, SM
Yang, K
Nyberg, F
Hemminki, K
Pershagen, G
Lambert, B
Citation: Sm. Hou et al., Hprt mutant frequency and aromatic DNA adduct level in non-smoking and smoking lung cancer patients and population controls, CARCINOGENE, 20(3), 1999, pp. 437-444
Authors:
Rajaniemi, H
Rasanen, I
Koivisto, P
Peltonen, K
Hemminki, K
Citation: H. Rajaniemi et al., Identification of the major tamoxifen-DNA adducts in rat liver by mass spectroscopy, CARCINOGENE, 20(2), 1999, pp. 305-309